1. Home
  2. CADL vs LE Comparison

CADL vs LE Comparison

Compare CADL & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.20

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo Lands' End Inc.

LE

Lands' End Inc.

HOLD

Current Price

$11.08

Market Cap

334.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
LE
Founded
1999
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
334.7M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
CADL
LE
Price
$6.20
$11.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$19.00
$32.50
AVG Volume (30 Days)
1.7M
366.8K
Earning Date
05-14-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
0.18
Revenue
$125,000.00
$1,162,769,000.00
Revenue This Year
N/A
$5.53
Revenue Next Year
N/A
$2.48
P/E Ratio
N/A
$63.50
Revenue Growth
N/A
0.72
52 Week Low
$4.34
$7.65
52 Week High
$7.66
$20.04

Technical Indicators

Market Signals
Indicator
CADL
LE
Relative Strength Index (RSI) 56.36 38.50
Support Level $5.42 $10.01
Resistance Level $6.41 $16.50
Average True Range (ATR) 0.48 0.57
MACD 0.09 0.11
Stochastic Oscillator 49.22 17.03

Price Performance

Historical Comparison
CADL
LE

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About LE Lands' End Inc.

Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.

Share on Social Networks: